With more than a decade of experience in private practice and government service, Jeremy Morrison's practice focuses on antitrust matters across a range of industries. His work centers primarily around complex antitrust compliance counseling, investigations, and mergers and acquisitions review before federal and state agencies, with extensive experience in consumer packaged goods, energy, technology, retail, and finance. He has counseled clients before the U.S. Department of Justice and Federal Trade Commission (FTC), as well as international tribunals including the European Commission and Canadian Competition Bureau. Jeremy has successfully represented a wide variety of clients through every stage of a deal.
Prior to rejoining Jones Day, Jeremy served as an attorney at the FTC, including as Counsel to the Director of the Bureau of Competition from 2013 to 2014. During his tenure at the FTC, Jeremy was the lead attorney on multiple merger investigations and prosecutions, including Pinnacle Entertainment's purchase of Ameristar Casinos and Albertson's acquisition of United Supermarkets. He also played an integral role in a number of high-profile FTC investigations and challenged transactions, including OSF Healthcare System's proposed acquisition of Rockford Health System, Reading Hospital's proposed acquisition of the Surgical Institute of Reading, Office Depot's affiliation with OfficeMax, and Grifols, S.A.'s acquisition of Talecris Biotherapeutics Holdings.
Jeremy, a member of the New York and District of Columbia Bars, is also active in the Antitrust Section of the American Bar Association.
FTC Resurrects Unilateral Preapproval in Merger Investigation Settlements to Halt Future "Anticompetitive" M&A and Introduces Changes to Second Request Reviews, The M&A Lawyer, Volume 25, Issue 10
FTC Resurrects Unilateral Preapproval in Merger Investigation Settlements to Halt Future "Anticompetitive" M&A
The Mystifying Antitrust Agency Clearance Process; Or How I Learned to Accept Disorder and Move Forward ,The M&A Lawyer, Vol. 25, Issue 8
Post-Election Reaction: Early Thoughts on a New Antitrust Regime, The M&A Lawyer, Volume 24, Issue 10
What You Need to Know About the New FTC DOJ Vertical Merger Guidelines, The M&A Lawyer, Volume 24, Issue 2
- August 2022
U.S. Antitrust Agencies Take Aim at Private Equity, The M&A Lawyer, Vol. 26, Issue 7
- December 2020
Post-Election Reaction: Early Thoughts on a New Antitrust Regime, The M&A Lawyer, Vol. 24, Issue 10
- April 2020
DOJ Prevails in Unprecedented Arbitration in Merger Challenge, Signaling More Arbitration in Future Merger Challenges, The M&A Lawyer, Vol. 24, Issue 4
- October 2018
Antitrust Training for HR Professionals: Is Your Compliance Programme Up-To-Date?, Competition Law International, Vol 14 No. 2.
Speaking Engagements Prior to Jones Day
June 12, 2013
Antitrust Analysis of Hospital Mergers, Federation of American Hospitals Policy Conference
June 26. 2012
An Overview of the Process: A Discussion on the Procedural Aspects of Merger Review, ABA Section of Antitrust Law
March 10, 2011
TransPerfect Legal Solutions/FTI Technology Second Request Panel
- Cornell University (J.D. 2007; Editor, Journal of Law and Public Policy); The University of Iowa (B.B.A. in Economics and Marketing 2002)
- District of Columbia and New York
- Served with the Federal Trade Commission (2010-2014) as Counsel to the Director of the Bureau of Competition and as Attorney, Mergers IV Division; Legislative Assistant and Press Secretary to Congressman James A. Leach (R-Iowa 2d) (2003-2004)
Global Competition Review (GCR) finalist for "Deal Lawyer of the Year — Under 40" (2020)